Glaxo Holdings

GSK is a leading global biopharmaceutical company headquartered in London, dedicated to the research, development, and manufacturing of innovative medicines and vaccines. The company focuses on four main therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. GSK is a world leader in vaccines, with a portfolio that includes treatments for shingles, meningitis, and respiratory syncytial virus (RSV). Through its majority-owned subsidiary ViiV Healthcare, the company is also a dominant player in the HIV treatment market. GSK's strategy emphasizes the science of the immune system and human genetics to develop next-generation therapies.